FZRQ — Immune Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Immune Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2013 December 31st	2014 December 31st	2015 December 31st	2016 December 31st	2017 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	0.049	6.77	4.54	0.271	6.78
Total Other Current Assets
Total Current Assets	0.267	6.89	4.83	0.644	7.03
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.047	0.041	0.371	0.316	0
Net Intangible Assets
Other Long Term Assets
Total Assets	31.5	37.9	36.2	19.1	28.6
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	11.3	7.42	6.29	9.16	9.25
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	26	20.3	26.7	16.6	14.8
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	5.48	17.5	9.52	2.51	13.8
Total Liabilities & Shareholders' Equity	31.5	37.9	36.2	19.1	28.6
Total Common Shares Outstanding
Total Preferred Shares Outstanding